ArticleOncology letters2023

BTK inhibitor combined with anti-PD-1 monoclonal antibody for the treatment of CD20-negative primary central nervous system lymphoma: A case report.

Lan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.